The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis.
about
Effect of methotrexate on bone and wound healing.Methotrexate for topical application in an extemporaneous preparation.Pharmacokinetic considerations in the treatment of inflammatory bowel disease.Interactions among Low Dose of Methotrexate and Drugs Used in the Treatment of Rheumatoid Arthritis.Occupational exposure to cytotoxic drugs in two UK oncology wards.The pharmacokinetic effect of coadministration of apremilast and methotrexate in individuals with rheumatoid arthritis and psoriatic arthritisPharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasisInvolvement of Multiple Transporters-mediated Transports in Mizoribine and Methotrexate Pharmacokinetics.Review article: The pharmacokinetics and pharmacodynamics of drugs used in inflammatory bowel disease treatment.Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel diseaseMechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers.Interaction of rhubarb and methotrexate in rats: in vivo and ex vivo approaches.Physiologically based pharmacokinetic modelling of methotrexate and 6-mercaptopurine in adults and children. Part 1: methotrexate.Simple and reliable HPLC method for the monitoring of methotrexate in osteosarcoma patients.Lack of interaction between flucloxacillin and methotrexate in patients with rheumatoid arthritis.Fostamatinib, a Syk-kinase inhibitor, does not affect methotrexate pharmacokinetics in patients with rheumatoid arthritis.A HPLC-SRM-MS based method for the detection and quantification of methotrexate in urine at doses used in clinical practice for patients with rheumatological disease: a potential measure of adherence
P2860
Q30235141-8F88F215-DB15-48A4-866E-51F78B8B1FC3Q30316265-D5666CD0-2318-4DF5-BCCA-320794F9CF52Q34437920-D4008187-A233-432D-8C3F-9111FB1EC554Q34758283-744020E6-0E7C-4FB7-A7C6-E75402D31F5DQ35496593-95756CC6-D6C5-4CAE-A58F-0D9353464457Q35741946-7D703D26-B52E-4BED-93C1-80986227B061Q35803952-551D9F42-3965-4BEB-A319-090CFAFF40CDQ37148784-233FE600-DDF0-4175-B733-CD9F17A7C012Q38501680-8E99710F-E75A-46B5-B32E-E3B7AEA90C15Q38660544-D611B2EC-DFE1-496C-BB5B-03C1A9633643Q38991972-84B5B286-A194-4F17-81A2-07E16B256983Q39063274-38A73071-B9ED-4254-AA1E-4DE25046D5F6Q44140105-9D97D2FC-8CDD-4583-9C0E-F6285259DF9AQ44252346-3C8DFCFA-872E-490F-B9A0-A7FF63EF9D75Q47633879-40FD6C4C-A798-4749-A8B4-D0CAF0DDFEBFQ48933623-253D0178-0399-4718-A9B3-F58FB47A9C84Q57323555-5BA4A7B0-6966-4186-9E0F-CAACB638060F
P2860
The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis.
description
1993 nî lūn-bûn
@nan
1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
The pharmacokinetics of methot ...... nts with rheumatoid arthritis.
@ast
The pharmacokinetics of methot ...... nts with rheumatoid arthritis.
@en
The pharmacokinetics of methot ...... nts with rheumatoid arthritis.
@nl
type
label
The pharmacokinetics of methot ...... nts with rheumatoid arthritis.
@ast
The pharmacokinetics of methot ...... nts with rheumatoid arthritis.
@en
The pharmacokinetics of methot ...... nts with rheumatoid arthritis.
@nl
prefLabel
The pharmacokinetics of methot ...... nts with rheumatoid arthritis.
@ast
The pharmacokinetics of methot ...... nts with rheumatoid arthritis.
@en
The pharmacokinetics of methot ...... nts with rheumatoid arthritis.
@nl
P2093
P2860
P1476
The pharmacokinetics of methot ...... nts with rheumatoid arthritis.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1993.TB04158.X
P407
P577
1993-04-01T00:00:00Z